文献速递流行病学与生物统计真实世界研究与卫生经济

印度喀拉拉邦糖尿病预防项目的同伴支持生活方式干预集群随机对照试验

A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program.
PubMed 文献 · PLoS Med · 2018-06-06

该研究在印度喀拉拉邦开展集群随机对照试验,纳入IDRS≥60且OGTT无糖尿病的30-60岁参与者1007人,评估12个月同伴支持生活方式干预对24个月糖尿病发病率的影响。结果显示干预组糖尿病发病率为14.9%,对照组为17.1%,差异无统计学意义(RR 0.88,95%CI 0.66-1.16,p=0.36),但干预组在IDRS评分、饮酒、果蔬摄入和HRQoL躯体功能方面有显著改善。

要点

  • 同伴支持干预未显著降低24个月糖尿病发病率(RR 0.88,95%CI 0.66-1.16,p=0.36)。
  • 干预组IDRS评分降低1.50分(p=0.022),果蔬摄入≥5份/天的RR为1.83(p=0.008)。
  • 干预组饮酒风险降低(RR 0.77,p=0.018),HRQoL躯体功能评分提高3.9分(p=0.016)。

核心结论

  • 低成本社区同伴支持生活方式干预在24个月时对高危人群糖尿病发病率的降低无统计学显著性。
  • 干预在部分心血管危险因素和HRQoL躯体功能评分方面有显著改善。

研究设计与样本

  • 集群随机对照试验,在印度喀拉拉邦Trivandrum区Neyyattinkara taluk的60个投票区(集群)开展。
  • 纳入年龄30-60岁、印度糖尿病风险评分(IDRS)≥60且口服葡萄糖耐量试验(OGTT)无糖尿病者,共1007人(对照组507人,干预组500人)。
  • 干预组接受12个月社区同伴支持项目,包括15次小组会议(其中12次由培训的非专业同伴领导者带领)及社区活动;对照组接受生活方式建议教育手册。
  • 主要结局为24个月时经年度OGTT诊断的糖尿病发病率;964人(95.7%)完成24个月随访。

主要发现

  • 中位随访24个月,对照组糖尿病发病率为17.1%(79/463),干预组为14.9%(68/456),相对风险(RR)0.88,95%CI 0.66-1.16,p=0.36。
  • 24个月时,干预组IDRS评分较对照组多降低1.50分(p=0.022)。
  • 干预组饮酒相对风险为0.77(p=0.018),果蔬摄入≥5份/天的相对风险为1.83(p=0.008)。
  • 干预组HRQoL量表躯体功能评分较对照组多提高3.9分(p=0.016)。
  • 同伴支持干预实施成本为每参与者22.5美元,未报告与干预相关的不良事件。

临床怎么用

  • 对于资源有限地区的高危人群,可考虑采用低成本同伴支持模式改善生活方式相关危险因素。
  • 该干预未显著降低糖尿病发病率,不能替代资源密集型糖尿病预防策略。

局限性

  • 未对多重比较进行调整,可能增加整体I型错误率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The major efficacy trials on diabetes prevention have used resource-intensive approaches to identify high-risk individuals and deliver lifestyle interventions. Such strategies are not feasible for wider implementation in low- and middle-income countries (LMICs). We aimed to evaluate the effectiveness of a peer-support lifestyle intervention in preventing type 2 diabetes among high-risk individuals identified on the basis of a simple diabetes risk score. METHODS AND FINDINGS: The Kerala Diabetes Prevention Program was a cluster-randomized controlled trial conducted in 60 polling areas (clusters) of Neyyattinkara taluk (subdistrict) in Trivandrum district, Kerala state, India. Participants (age 30-60 years) were those with an Indian Diabetes Risk Score (IDRS) ≥60 and were free of diabetes on an oral glucose tolerance test (OGTT). A total of 1,007 participants (47.2% female) were enrolled (507 in the control group and 500 in the intervention group). Participants from intervention clusters participated in a 12-month community-based peer-support program comprising 15 group sessions (12 of which were led by trained lay peer leaders) and a range of community activities to support lifestyle change. Participants from control clusters received an education booklet with lifestyle change advice. The primary outcome was the incidence of diabetes at 24 months, diagnosed by an annual OGTT. Secondary outcomes were behavioral, clinical, and biochemical characteristics and health-related quality of life (HRQoL). A total of 964 (95.7%) participants were followed up at 24 months. Baseline characteristics of clusters and participants were similar between the study groups. After a median follow-up of 24 months, diabetes developed in 17.1% (79/463) of control participants and 14.9% (68/456) of intervention participants (relative risk [RR] 0.88, 95% CI 0.66-1.16, p = 0.36). At 24 months, compared with the control group, intervention participants had a greater reduction in IDRS score (mean difference: -1.50 points, p = 0.022) and alcohol use (RR 0.77, p = 0.018) and a greater increase in fruit and vegetable intake (≥5 servings/day) (RR 1.83, p = 0.008) and physical functioning score of the HRQoL scale (mean difference: 3.9 score, p = 0.016). The cost of delivering the peer-support intervention was US$22.5 per participant. There were no adverse events related to the intervention. We did not adjust for multiple comparisons, which may have increased the overall type I error rate. CONCLUSIONS: A low-cost community-based peer-support lifestyle intervention resulted in a nonsignificant reduction in diabetes incidence in this high-risk population at 24 months. However, there were significant improvements in some cardiovascular risk factors and physical functioning score of the HRQoL scale. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Registry ACTRN12611000262909.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Thankappan KR, Sathish T, Tapp RJ, et al. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program. PLoS Med. 2018. PMID: 29874236. doi:10.1371/journal.pmed.1002575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。